🇺🇸 Human Plasma in United States

243 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Off Label Use — 68 reports (27.98%)
  2. Drug Ineffective — 52 reports (21.4%)
  3. Condition Aggravated — 18 reports (7.41%)
  4. Pneumonia — 17 reports (7%)
  5. Anaemia — 16 reports (6.58%)
  6. Product Use In Unapproved Indication — 16 reports (6.58%)
  7. Septic Shock — 16 reports (6.58%)
  8. Covid-19 — 14 reports (5.76%)
  9. Cognitive Disorder — 13 reports (5.35%)
  10. Hypotension — 13 reports (5.35%)

Source database →

Human Plasma in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Human Plasma approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Human Plasma in United States?

Ottawa Hospital Research Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.